- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 458630745
- Drug.IUPAC_name
- (1S,3aR,6aS)-2-[(2S)-2-[[(2S)-2-Cyclohexyl-2-(pyrazine-2-carbonylamino)acetyl]amino]-3,3-dimethylbutanoyl]-N-[(3S)-1-(cyclopropylamino)-1,2-dioxohexan-3-yl]-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-1-carboxamide
| image = Telaprevir structure.svg
| image_class = skin-invert-image
| width = 280
| tradename = Incivek, Incivo
| Drugs.com =
| MedlinePlus = a611038
| licence_US = Telaprevir
| pregnancy_AU =
| pregnancy_US = B
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US = Rx-only
| legal_status =
| routes_of_administration = Oral
| bioavailability =
| protein_bound = 59–76%
| metabolism = extensive hepatic
| elimination_half-life = 9–11 hours
| excretion = 90% (bile), 9% (exhaled air), 1% (urine)
| IUPHAR_ligand = 7871
| CAS_number_Ref =
| CAS_number = 402957-28-2
| ATC_prefix = J05
| ATC_suffix = AP02
| ChEBI_Ref =
| ChEBI = 68595
| ChEMBL_Ref =
| ChEMBL = 231813
| PubChem = 3010818
| DrugBank_Ref =
| DrugBank = DB05521
| ChemSpiderID_Ref =
| ChemSpiderID = 2279948
| UNII_Ref =
| UNII = 655M5O3W0U
| KEGG_Ref =
| KEGG = D09012
| NIAID_ChemDB = 213006
| C=36 | H=53 | N=7 | O=6
| StdInChI_Ref =
| StdInChI = 1S/C36H53N7O6/c1-5-10-25(29(44)34(48)39-23-15-16-23)40-33(47)28-24-14-9-13-22(24)20-43(28)35(49)30(36(2,3)4)42-32(46)27(21-11-7-6-8-12-21)41-31(45)26-19-37-17-18-38-26/h17-19,21-25,27-28,30H,5-16,20H2,1-4H3,(H,39,48)(H,40,47)(H,41,45)(H,42,46)/t22-,24-,25-,27-,28-,30+/m0/s1
| StdInChIKey_Ref =
| StdInChIKey = BBAWEDCPNXPBQM-GDEBMMAJSA-N
| SMILES = CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)c5cnccn5
| SMILES2 = C0CC0NC(=O)C(=O)[C@H](CCC)NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C3CCCCC3)NC(=O)c4nccnc4